LB54640
A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic Obesity
Rhythm · Phase 2 · Status n/r · Enrollment 4
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| POMC/PCSK1/LEPR cohort | Obesity or overweight | n/r | n/r | n/r | n/r |